Vimarsana
Biggest News Aggregation in the World

Page 15 - Xlife Sciences News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Xlife Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Xlife Sciences Today - Breaking & Trending Today

NewsNow: Austria Coronavirus news | Breaking News 24/7 - Vimarsana News

NewsNow: Austria Coronavirus news | Breaking News 24/7

Track breaking Austria Coronavirus headlines on NewsNow: the one-stop shop for Austria Coronavirus news

Investegate |Xlife Sciences AG Announcements | Xlife Sciences AG: Successful license deal with Vitese Trading GmbH - Vimarsana News

Investegate |Xlife Sciences AG Announcements | Xlife Sciences AG: Successful license deal with Vitese Trading GmbH

Investegate announcements from Xlife Sciences AG, Successful license deal with Vitese Trading GmbH

Xlife Sciences AG: Successful License Deal with Vitese Trading GmbH - Vimarsana News

Xlife Sciences AG: Successful License Deal with Vitese Trading GmbH

Inflamed pharma GmbH signs license agreement with Vitesse Trading GmbHZURICH, SWITZERLAND / ACCESSWIRE / October 7, 2021 / The Xlife-project company inflamed pharma GmbH has concluded an exclusive license

VERAXA Biotech and Quadira Biosciences Enter Partnership on ADC Development - Vimarsana News

VERAXA Biotech and Quadira Biosciences Enter Partnership on ADC Development

Search jobs VERAXA Biotech and Quadira Biosciences Enter Partnership on ADC Development HEIDELBERG, Germany and ZUG, Switzerland, June 14, 2021 / B3C newswire / --VERAXA Biotech GmbH (former Velabs Therapeutics GmbH), a leading company in innovative ADC engineering and functional antibody screening, announced today that it has entered into a partnership agreement with Quadira Biosciences AG, Zug, Switzerland, to jointly develop a suite of novel ADCs for the treatment of oncological conditions. The collaboration will leverage both the advantages of VERAXA's advanced an...

Xlife Sciences AG: Breakthrough in Drug Development - Vimarsana News

Xlife Sciences AG: Breakthrough in Drug Development

First available holistic medical drug to treat Covid-19 and flu viruses ZUERICH, SWITZERLAND / ACCESSWIRE / June 10, 2021 / As a project company of Xlife Sciences AG (XLS DE), inflamed pharma GmbH has